Quantra QPlus in Pediatric Cardiovascular Procedures

Starting soon

Conditions studied: Blood Loss, Surgical

In brief

This study will evaluate the performance of the Quantra System with the QPlus Cartridge in pediatric patients undergoing cardiovascular procedures.

Key facts

Study ID

NCT07597278

Run by

HemoSonics LLC

People needed

160

Starts

2026-09-25

Expected to finish

2027-10-15

Last updated by the study team

2026-05-19

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is <18 years of age.
• Subject is undergoing a cardiovascular procedure OR subject underwent cardiovascular surgery and presents with acute bleeding or suspected hypocoagulation/hypercoagulation in a post-surgical unit.
• Subject's parent(s) or guardian(s) has signed an informed consent form. If required, subject has signed an assent form.

You may not qualify if…

• Corrected gestational age <37 weeks.
• Subject is enrolled in a study that might confound the result of the proposed study.
• Subject is affected by a condition that, in the opinion of the clinical team, may pose additional risks.

Where it is running

• UCLA Mattel Children's Hospital — Los Angeles, California, United States
• Children's Healthcare of Atlanta — Atlanta, Georgia, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.